Jane Street
IOVA icon

Jane Street’s Iovance Biotherapeutics IOVA Stock Holding History

Jane Street’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$980K Buy
279,100
+148,500
+114% +$475K ﹤0.01% 6538
2025
Q4 		$357K Buy
130,600
+28,300
+28% +$65.5K ﹤0.01% 8443
2025
Q3 		$222K Sell
102,300
-138,300
-57% -$327K ﹤0.01% 9470
2025
Q2 		$414K Buy
240,600
+59,800
+33% +$149K ﹤0.01% 7286
2025
Q1 		$602K Buy
180,800
+32,600
+22% +$168K ﹤0.01% 6522
2024
Q4 		$1.1M Sell
148,200
-1,841,500
-93% -$17.1M ﹤0.01% 5203
2024
Q3 		$18.7M Buy
1,989,700
+772,700
+63% +$7.32M ﹤0.01% 1293
2024
Q2 		$9.76M Buy
1,217,000
+293,500
+32% +$3.15M ﹤0.01% 2083
2024
Q1 		$13.7M Buy
923,500
+754,300
+446% +$8.78M ﹤0.01% 1513
2023
Q4 		$1.38M Sell
169,200
-152,400
-47% -$797K ﹤0.01% 4981
2023
Q3 		$1.46M Buy
321,600
+254,900
+382% +$1.66M ﹤0.01% 4565
2023
Q2 		$470K Buy
66,700
+26,600
+66% +$190K ﹤0.01% 6414
2023
Q1 		$245K Sell
40,100
-143,500
-78% -$990K ﹤0.01% 7513
2022
Q4 		$1.17M Buy
183,600
+56,100
+44% +$438K ﹤0.01% 4731
2022
Q3 		$1.22M Sell
127,500
-118,000
-48% -$1.36M ﹤0.01% 5053
2022
Q2 		$2.71M Buy
245,500
+52,100
+27% +$683K ﹤0.01% 3618
2022
Q1 		$3.22M Buy
193,400
+74,300
+62% +$1.15M ﹤0.01% 3804
2021
Q4 		$2.27M Buy
119,100
+38,900
+49% +$856K ﹤0.01% 4222
2021
Q3 		$1.98M Sell
80,200
-86,500
-52% -$2.04M ﹤0.01% 4505
2021
Q2 		$4.34M Buy
166,700
+117,600
+240% +$3.06M ﹤0.01% 2893
2021
Q1 		$1.55M Sell
49,100
-73,200
-60% -$3.03M ﹤0.01% 4513
2020
Q4 		$5.67M Buy
122,300
+67,300
+122% +$2.67M ﹤0.01% 1985
2020
Q3 		$1.81M Sell
55,000
-87,400
-61% -$2.68M ﹤0.01% 3198
2020
Q2 		$3.91M Buy
142,400
+41,200
+41% +$1.35M ﹤0.01% 2150
2020
Q1 		$3.03M Buy
+101,200
New +$2.68M ﹤0.01% 1615

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Jane Street's IOVA Position: Q1 2026 in Review

Jane Street increased its Iovance Biotherapeutics (IOVA) stake by 16% in Q1 2026, buying an estimated $1.89M and bringing the position to 4,173,886 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

Jane Street first reported a position in IOVA in Q3 2017 and has held it in 29 quarters since. The position peaked at $15.1M in Q1 2024. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Jane Street held 4,173,886 shares of Iovance Biotherapeutics worth $14.7M as of Q1 2026.
  • Jane Street bought 590,076 Iovance Biotherapeutics shares in Q1 2026, an estimated $1.89M.
  • Iovance Biotherapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2089 holding.
  • Jane Street first reported a position in Iovance Biotherapeutics in Q3 2017 and has held it in 29 quarters since.
  • Jane Street's Iovance Biotherapeutics position peaked at $15.1M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.